Treatment of multidrug-resistant tuberculosis in Indonesia

Hadiarto Mangunnegoro; Aditama Tjandra; Achmad Hudoyo

doi:10.1159/000239511

Treatment of multidrug-resistant tuberculosis in Indonesia

Hadiarto Mangunnegoro, Aditama Tjandra, Achmad Hudoyo

Department of Pulmonology and Respiratory Medicine

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Abstract

There is growing concern, even among developed countries, about the increasing incidence of multidrug-resistant tuberculosis (MDR-TB). Results are reported from a study investigating ofloxacin used in the treatment of 57 patients with MDR-TB. Patients received ofloxacin 400 mg/day as well as three other sensitive anti-TB drugs based on susceptibility tests. Treatment duration was 9 months. Preliminary results of 35 evaluable patients show 55% of MDR-TB cases converted to smear and culture negative within 3 months of therapy. Ofloxacin in combination with other sensitive anti-TB medication shows promise in the treatment of MDR-TB and further studies are recommended.

Original language	English
Pages (from-to)	24-29
Number of pages	6
Journal	Chemotherapy
Volume	42
DOIs	https://doi.org/10.1159/000239511
Publication status	Published - 1 Jan 1996

Keywords

Drug resistance
Multidrug-resistant tuberculosis
Ofloxacin

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1159/000239511

Cite this

@article{47d4dca9e5424b59970d63bf9354f3d6,

title = "Treatment of multidrug-resistant tuberculosis in Indonesia",

abstract = "There is growing concern, even among developed countries, about the increasing incidence of multidrug-resistant tuberculosis (MDR-TB). Results are reported from a study investigating ofloxacin used in the treatment of 57 patients with MDR-TB. Patients received ofloxacin 400 mg/day as well as three other sensitive anti-TB drugs based on susceptibility tests. Treatment duration was 9 months. Preliminary results of 35 evaluable patients show 55% of MDR-TB cases converted to smear and culture negative within 3 months of therapy. Ofloxacin in combination with other sensitive anti-TB medication shows promise in the treatment of MDR-TB and further studies are recommended.",

keywords = "Drug resistance, Multidrug-resistant tuberculosis, Ofloxacin",

author = "Hadiarto Mangunnegoro and Aditama Tjandra and Achmad Hudoyo",

year = "1996",

month = jan,

day = "1",

doi = "10.1159/000239511",

language = "English",

volume = "42",

pages = "24--29",

journal = "Chemotherapy",

issn = "0009-3157",

publisher = "S. Karger AG",

}

TY - JOUR

T1 - Treatment of multidrug-resistant tuberculosis in Indonesia

AU - Mangunnegoro, Hadiarto

AU - Tjandra, Aditama

AU - Hudoyo, Achmad

PY - 1996/1/1

Y1 - 1996/1/1

N2 - There is growing concern, even among developed countries, about the increasing incidence of multidrug-resistant tuberculosis (MDR-TB). Results are reported from a study investigating ofloxacin used in the treatment of 57 patients with MDR-TB. Patients received ofloxacin 400 mg/day as well as three other sensitive anti-TB drugs based on susceptibility tests. Treatment duration was 9 months. Preliminary results of 35 evaluable patients show 55% of MDR-TB cases converted to smear and culture negative within 3 months of therapy. Ofloxacin in combination with other sensitive anti-TB medication shows promise in the treatment of MDR-TB and further studies are recommended.

AB - There is growing concern, even among developed countries, about the increasing incidence of multidrug-resistant tuberculosis (MDR-TB). Results are reported from a study investigating ofloxacin used in the treatment of 57 patients with MDR-TB. Patients received ofloxacin 400 mg/day as well as three other sensitive anti-TB drugs based on susceptibility tests. Treatment duration was 9 months. Preliminary results of 35 evaluable patients show 55% of MDR-TB cases converted to smear and culture negative within 3 months of therapy. Ofloxacin in combination with other sensitive anti-TB medication shows promise in the treatment of MDR-TB and further studies are recommended.

KW - Drug resistance

KW - Multidrug-resistant tuberculosis

KW - Ofloxacin

UR - http://www.scopus.com/inward/record.url?scp=0029855389&partnerID=8YFLogxK

U2 - 10.1159/000239511

DO - 10.1159/000239511

M3 - Article

C2 - 8980865

AN - SCOPUS:0029855389

SN - 0009-3157

VL - 42

SP - 24

EP - 29

JO - Chemotherapy

JF - Chemotherapy

ER -

Treatment of multidrug-resistant tuberculosis in Indonesia

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this